A year-ahead roundup on health plan M&A, autonomous care, CMS ACCESS, rising costs, and where innovation is actually heading.
This week’s news and headlines unpacked, plus a Q&A with Jacquelyn Miller
This week’s news and headlines unpacked, plus a Q&A with Rushika Fernandopulle
As Americans juggle cash-pay care and high-deductible insurance, companies like Aidoc, Datavant, and Prosper AI are testing whether tech can ease the pressure.
As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness - and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!
Why “Power Law” venture math is more challenging for value-based care, versus fee-for-service, and whether AI will make a difference
For my book, The Storyteller’s Advantage, I interviewed dozens of CEOs about how they developed effective narratives - and what you can learn from them
"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.
Plus fresh funding rounds and 4 Questions with Commons Clinic’s SVP of Care Services & Strategy.
Why funding has slowed, where gaps remain, and what the next wave of innovation could look like.
Plus Peloton's surprise profit, 4 Questions with the CSO of Solera Health and a hot-take on AI driven automation.
A comprehensive review of the oral healthcare space that includes a market map
One tiny fund I hadn’t heard of absolutely crushed it
When to raise, how much & from whom?
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
A few thoughts...
And what are the pros and cons?
Some digital health companies are getting more targeted with their approach
Because so many of you asked for it!
Things have gotten a little better in digital health VC land, but it’s still challenging out there!
Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto
The company closed up shop abruptly this week.
With Tom Cassels, who’s sat on plenty of boards as an independent director
One longtime women's health investor weighs in...
